Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARG | P13631 | 1/20 | 0.41 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.35 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.33 |
| ▸ | TUBB | P07437 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2947022 | 0.83 | PTGS2 (0.47) | RARGRXRAPPARGCA1CA2 | |
| SCHEMBL4855803 | 0.81 | EGFR (0.34) | RARGRXRAPPARGCA1CA2 | |
| SCHEMBL4863445 | 0.80 | RXRA (0.44) | RARGRXRAPPARGPTGS2CYP3A4 | |
| SCHEMBL31063374 | 0.79 | GABRA1 (0.34) | TP53GABRA1GABRB2TUBB4ATUBB | |
| SCHEMBL4297642 | 0.78 | ALOX15 (0.46) | RARGRXRAPPARGCA1CA2 | |
| SCHEMBL14817161 | 0.78 | RARG (0.40) | RARGRXRAPPARGCA1CA2 | |
| SCHEMBL13688744 | 0.78 | ALDH1A1 (0.42) | RARGRXRAPPARGCA1CA2 | |
| SCHEMBL4852936 | 0.78 | RXRA (0.46) | RARGRXRAPPARGCYP3A4TSHR | |
| SCHEMBL4856035 | 0.76 | RXRA (0.47) | RARGRXRAPPARGALOX15ALDH1A1 | |
| SCHEMBL4860379 | 0.76 | RXRA (0.47) | RARGRXRAPPARGLMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250206766-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-06-26 | — | — | US | disclosed |
| CN-120157714-A | Organic electroluminescent material and device | 环球展览公司 | 2025-06-17 | — | — | CN | disclosed |
| EP-2456793-A1 | CATALYSTS BASED ON 2-(2-ARYLOXY) QUINOLINE OR 2-(2-ARYLOXY) DIHYDROQUNIOLINE LIGANDS | Equistar Chemicals, LP (US) | 2012-05-30 | — | — | EP | disclosed |
| EP-2456795-A1 | METHOD OF PREPARING NON-METALLOCENE CATALYSTS | Equistar Chemicals, LP (US) | 2012-05-30 | — | — | EP | disclosed |
| US-8158733-B2 | Catalysts based on 2-(2-aryloxy)quinoline or 2-(2-aryloxy)dihydroquinoline ligands | EQUISTAR CHEMICALS, LP (US) | 2012-04-17 | — | — | US | disclosed |
| US-8158733-B2 | Catalysts based on 2-(2-aryloxy)quinoline or 2-(2-aryloxy)dihydroquinoline ligands | EQUISTAR CHEMICALS, LP (US) | 2012-04-17 | — | — | US | disclosed |
| US-8158733-B2 | Catalysts based on 2-(2-aryloxy)quinoline or 2-(2-aryloxy)dihydroquinoline ligands | EQUISTAR CHEMICALS, LP (US) | 2012-04-17 | — | — | US | disclosed |
| US-8153544-B2 | Method for preparing non-metallocene catalysts | EQUISTAR CHEMICALS, LP (US) | 2012-04-10 | — | — | US | disclosed |
| US-8153544-B2 | Method for preparing non-metallocene catalysts | EQUISTAR CHEMICALS, LP (US) | 2012-04-10 | — | — | US | disclosed |
| US-8153544-B2 | Method for preparing non-metallocene catalysts | EQUISTAR CHEMICALS, LP (US) | 2012-04-10 | — | — | US | disclosed |
| WO-2011011039-A1 | METHOD OF PREPARING NON-METALLOCENE CATALYSTS | EQUISTAR CHEMICALS, LP (US) | 2011-01-27 | — | — | WO | disclosed |
| WO-2011011039-A1 | METHOD OF PREPARING NON-METALLOCENE CATALYSTS | EQUISTAR CHEMICALS, LP (US) | 2011-01-27 | — | — | WO | disclosed |
| US-20110021344-A1 | Method for preparing non-metallocene ligands | EQUISTAR CHEMICALS, LP | 2011-01-27 | — | — | US | disclosed |
| US-20110021344-A1 | Method for preparing non-metallocene ligands | EQUISTAR CHEMICALS, LP | 2011-01-27 | — | — | US | disclosed |
| US-20110021344-A1 | Method for preparing non-metallocene ligands | EQUISTAR CHEMICALS, LP | 2011-01-27 | — | — | US | disclosed |
| US-20110021727-A1 | Catalysts based on 2-(2-aryloxy)quinoline or 2-(2-aryloxy)dihydroquinoline ligands | EQUISTAR CHEMICALS, LP | 2011-01-27 | — | — | US | disclosed |
| US-20110021727-A1 | Catalysts based on 2-(2-aryloxy)quinoline or 2-(2-aryloxy)dihydroquinoline ligands | EQUISTAR CHEMICALS, LP | 2011-01-27 | — | — | US | disclosed |
| US-6924388-B2 | Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2005-08-02 | — | — | US | disclosed |
| US-20040092594-A1 | Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2004-05-13 | — | — | US | disclosed |
| US-6632963-B1 | Are useful for the treatment of a wide variety of disease states, whether human or veterinary, for example dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders, as well as for the treatment of | GALDERMA RESEARCH & DEVELOPMENT S.N.C. (FR) | 2003-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092594-A1 | Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof | AHR, TYR, MC1R | RARG 302/4885RXRA 174/4885PPARG 61/4885 |
| US-20250206766-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, L1CAM, OCIAD2 | RARG 4033/4885RXRA 3764/4885PPARG 2358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.